Alison is an articling student at Tyr LLP. She is an enthusiastic and engaged trainee.
Alison recently completed her law degree at Osgoode Hall Law School.
Alison is passionate about advocacy. As a caseworker at Osgoode’s Investor Protection Clinic, Alison advocated for harmed investors in submissions to the Department of Finance Canada’s National Anti-Fraud Strategy Consultation and the Ombudsman for Banking Services and Investments 2026 Independent Review. During law school, Alison also worked at the IP Innovation Clinic and the Community & Legal Aid Services Program where she helped prepare a motion to intervene before the Supreme Court of Canada.
Before law school, Alison completed her M.Sc. in Population and Public Health with a concentration in Health Economics at the University of British Columbia. During her Master’s program, Alison spent a year as a research fellow at Harvard Medical School and Harvard Pilgrim Health Care Institute. Alison also holds a B.Sc. (Hons) in Cellular, Molecular, and Microbiology with a minor in Philosophy, as well as a Doctor of Pharmacy (PharmD) degree.
Recognitions
- First place team, OpenJustice Benchmarkathon (2026)
- Dominic Carinci Memorial Prize, OHLS (2026)
- Michael Smith Foreign Study Supplement, CIHR (2022)
- Faculty of Medicine Graduate Award, UBC (2021)
- Canada Graduate Scholarship – Master’s (CGS-M), CIHR (2021-2022)
- PharmD Experiential Education Award, UBC (2017)
- Shoppers Drug Mart Terry Morrison Scholarship, UBC (2017)
- Lieutenant-Governor’s Medal, TRU (2015)
- Undergraduate Research Experience Award, TRU (2014)
Publications
- McClean AR et al. Changing tides? Anticancer biologic and biosimilar use in Medicare Part B, (2019-2021. JCO Oncol Pract. 2023
McClean AR et al. Uptake of biosimilar drugs in Canada: analysis of provincial policies and usage data. CMAJ. 2022. 194(15): E556-E560
- McClean AR et al. Uptake and spending on biosimilar infliximab and etanercept after new start and switching policies in Canada: An interrupted time series analysis. Arthritis Care Res. 2023. 75(9): 2011-2021
- McClean AR et al. Tobacco smoking and HIV-related immunologic and virologic response among individuals of the Canadian HIV Observational Cohort (CANOC). AIDS Care. 2022. 34(8): 982-991
- McClean AR et al. Neighbourhood level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort Collaboration (CANOC): A longitudinal cohort study. CMAJ Open. 2022. 10(1): E183-E189
- McClean AR et al. Longitudinal cohort trends in combination antiretroviral therapy use and treatment response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A longitudinal cohort study. Can J Hosp Pharm. 2022. 75(4): 309-16
In addition, Alison is a collaborating author in seven publications in the Canadian Journal of Cardiology, Annals of Pharmacotherapy, Thrombosis and Haemostasis, International Journal of Population Data Science, Journal of Antimicrobial Chemotherapy, HIV Medicine, and AIDS.
Professional Affiliations
- Student Member, The Advocates’ Society
- Student Member, Intellectual Property Institute of Canada
Education
- Osgoode Hall Law School, JD, 2026
- University of British Columbia, Master of Science, 2022
- University of British Columbia, Doctor of Pharmacy, 2019
- Thompson Rivers University, Bachelor of Science (Hons), 2014
